# Sumatriptan

## Imigran FDT 50mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OIMI5                                                                                                                                                                                                                                                                                                                                                                                                          |
| Indications        | Acute relief of migraine attacks with or without aura.                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Migraine， acute:Adult: 50-100 mg as single dose. Further doses at 2 hours interval may be given in the next 24 hours. Maximum: 300 mg/24 hours.                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Previous MI， ischaemic heart disease (IHD)， Prinzmetal's angina/coronary vasospasm， peripheral vascular disease or patients who have symptoms or signs consistent with IHD; history of previous CVA or transient ischaemic attack (TIA); uncontrolled HTN; severe hepatic impairment. Concomitant use of ergotamine or its derivatives (including methysergide)， MAOIs or use within 2 wk of MAOI therapy. |
| Adverse Effects    | Tingling， dizziness， drowsiness; transient increase in BP， flushing， nausea & vomiting; sensations of heaviness， heat， pressure or tightness; pain， feelings of weakness， fatigue.                                                                                                                                                                                                                     |
| Pregnancy          | No (limited) human data – animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                  |

